{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:07:46Z","timestamp":1788998866874,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["Grant Number 22K15415"],"award-info":[{"award-number":["Grant Number 22K15415"]}]},{"name":"he Miyakawa Memorial Research Foundation","award":["Grant-in-Aid, 2025"],"award-info":[{"award-number":["Grant-in-Aid, 2025"]}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["AMED no.JP25fk0210150h0002"],"award-info":[{"award-number":["AMED no.JP25fk0210150h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57253-3","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:55:53Z","timestamp":1781956553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide DNA methylation profiling during metabolic dysfunction-associated steatohepatitis-related hepatocarcinogenesis in patients in Japan and the United States"],"prefix":"10.1038","volume":"16","author":[{"given":"Junko","family":"Kuramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Muramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhide","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Nammo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley Jane","family":"Evason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"57253_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","journal-title":"J. Hepatol."},{"key":"57253_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000786","author":"X Wang","year":"2024","unstructured":"Wang, X., Zhang, L. & Dong,. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology https:\/\/doi.org\/10.1097\/HEP.0000000000000786 (2024).","journal-title":"Hepatology"},{"key":"57253_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"16","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 16, 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57253_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones, P. A., Issa, J. P. & Baylin, S. Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17, 630\u2013641 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"57253_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-nutr-121415-112634","volume":"36","author":"C Sapienza","year":"2016","unstructured":"Sapienza, C. & Issa, J. P. Diet, nutrition, and cancer epigenetics. Annu. Rev. Nutr. 36, 665\u2013681 (2016).","journal-title":"Annu. Rev. Nutr."},{"key":"57253_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/pin.13418","volume":"74","author":"Y Kanai","year":"2024","unstructured":"Kanai, Y. Molecular pathological approach to cancer epigenomics and its clinical application. Pathol. Int. 74, 167\u2013186 (2024).","journal-title":"Pathol. Int."},{"key":"57253_CR7","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein, M., Nejman, D., Greenfield, R. & Cedar, H. DNA methylation in cancer and aging. Cancer Res. 76, 3446\u20133450 (2016).","journal-title":"Cancer Res."},{"key":"57253_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/carcin\/bgaa115","volume":"42","author":"K Hamada","year":"2021","unstructured":"Hamada, K. et al. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of \u2018pan-negative\u2019-type lung adenocarcinomas. Carcinogenesis 42, 169\u2013179 (2021).","journal-title":"Carcinogenesis"},{"key":"57253_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/carcin\/bgaa079","volume":"41","author":"M Yang","year":"2020","unstructured":"Yang, M. et al. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways. Carcinogenesis 41, 1473\u20131484 (2020).","journal-title":"Carcinogenesis"},{"key":"57253_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/carcin\/bgx005","volume":"38","author":"J Kuramoto","year":"2017","unstructured":"Kuramoto, J. et al. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: Comparison with hepatitis virus-related carcinogenesis. Carcinogenesis 38, 261\u2013270 (2017).","journal-title":"Carcinogenesis"},{"key":"57253_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00432-020-03298-4","volume":"146","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas. J. Cancer Res. Clin. Oncol. 146, 2461\u20132477 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"57253_CR12","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1007\/s00432-022-04445-9","volume":"149","author":"N Tsuda","year":"2023","unstructured":"Tsuda, N. et al. DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas. J. Cancer Res. Clin. Oncol. 149, 5109\u20135125 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"57253_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1872-034X.2011.00929.x","volume":"42","author":"Y Nagaoki","year":"2012","unstructured":"Nagaoki, Y. et al. Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatol. Res. 42, 368\u2013375 (2012).","journal-title":"Hepatol. Res."},{"key":"57253_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"57253_CR15","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt, E. M. et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467\u20132474 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"57253_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/00325481.2024.2325332","volume":"136","author":"AM Allen","year":"2024","unstructured":"Allen, A. M. et al. Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgrad. Med. 136, 229\u2013245 (2024).","journal-title":"Postgrad. Med."},{"key":"57253_CR17","unstructured":"Torbenson, M. S. et al. Hepatocellular carcinoma. In: World Health Organization Classification of Tumours. Digestive System Tumours, 5th ed., vol. 1, 229\u2013239 (IARC Press, Lyon, 2019)."},{"key":"57253_CR18","first-page":"80","volume-title":"TNM Classification of Malignant Tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley, J. D., Gospodarowicz, M. K. & Wittekind, C. Liver cell carcinoma. In TNM Classification of Malignant Tumours 8th ed. 80\u201382 (Wiley-Liss, 2017).","edition":"8th ed."},{"issue":"Suppl","key":"57253_CR19","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31(Suppl), S32\u2013S50 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"57253_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/pin.12631","volume":"68","author":"Y Kanai","year":"2018","unstructured":"Kanai, Y. et al. The Japanese Society of Pathology guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses. Pathol. Int. 68, 63\u201390 (2018).","journal-title":"Pathol. Int."},{"key":"57253_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/pin.12716","volume":"68","author":"K Ohara","year":"2018","unstructured":"Ohara, K. et al. Feasibility of methylome analysis using small amounts of genomic DNA from formalin-fixed paraffin-embedded tissue. Pathol Int. 68, 633\u2013635 (2018).","journal-title":"Pathol Int."},{"key":"57253_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2217\/epi.09.14","volume":"200","author":"MLJ Bibikova","year":"2009","unstructured":"Bibikova, M. L. J. et al. Genome-wide DNA methylation profiling using Infinium\u00ae assay. Epigenomics 200, 177\u2013200 (2009).","journal-title":"Epigenomics"},{"key":"57253_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13148-022-01379-4","volume":"14","author":"J Kuramoto","year":"2022","unstructured":"Kuramoto, J. et al. Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis. Clin. Epigenetics 14, 168 (2022).","journal-title":"Clin. Epigenetics"},{"key":"57253_CR24","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e74","volume":"33","author":"T Hirano","year":"2022","unstructured":"Hirano, T. et al. Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles. J. Gynecol. Oncol. 33, e74 (2022).","journal-title":"J. Gynecol. Oncol."},{"key":"57253_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/15592294.2020.1767374","volume":"15","author":"M Fujimoto","year":"2020","unstructured":"Fujimoto, M. et al. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis. Epigenetics 15, 1289\u20131301 (2020).","journal-title":"Epigenetics"},{"key":"57253_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"N Turner","year":"2010","unstructured":"Turner, N. et al. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116\u2013129 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"57253_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","volume":"267","author":"T Helsten","year":"2016","unstructured":"Helsten, T. et al. The FGFR landscape in cancer: Analysis of 4,853 tumors by next-generation sequencing. Clin. Cancer Res. 267, 259\u2013267 (2016).","journal-title":"Clin. Cancer Res."},{"key":"57253_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.26890","volume":"1434","author":"Y Arai","year":"2014","unstructured":"Arai, Y. et al. Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 1434, 1427\u20131434 (2014).","journal-title":"Hepatology"},{"key":"57253_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00595-019-01953-z","volume":"50","author":"K Tada","year":"2020","unstructured":"Tada, K. et al. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma. Surg. Today 50, 767\u2013777 (2020).","journal-title":"Surg. Today"},{"key":"57253_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.281","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Cell Death Dis. 8, e2892 (2017).","journal-title":"Cell Death Dis."},{"key":"57253_CR31","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1038\/cddis.2013.450","volume":"4","author":"L Cheng","year":"2013","unstructured":"Cheng, L. et al. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K\/Akt signaling pathway. Cell Death Dis. 4, e923 (2013).","journal-title":"Cell Death Dis."},{"key":"57253_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0076-6879(06)16006-1","volume":"416","author":"A Togayachi","year":"2006","unstructured":"Togayachi, A. et al. Comprehensive enzymatic characterization of glycosyltransferases with a beta3GT or beta4GT motif. Methods Enzymol. 416, 91\u2013102 (2006).","journal-title":"Methods Enzymol."},{"issue":"25","key":"57253_CR33","doi-asserted-by":"publisher","first-page":"22032","DOI":"10.1074\/jbc.M011369200","volume":"276","author":"A Togayachi","year":"2001","unstructured":"Togayachi, A. et al. Molecular cloning and characterization of UDP-GlcNAc: Lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J. Biol. Chem. 276(25), 22032\u201322040 (2001).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"57253_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/glycob\/cws061","volume":"22","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. High expression of lactotriaosylceramide, a diferentiation-associated glycosphingolipid, in the bone marrow of acute myeloid leukemia patients. Glycobiology 22(7), 930\u2013938 (2012).","journal-title":"Glycobiology"},{"issue":"11","key":"57253_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/cns.13439","volume":"26","author":"H Jeong","year":"2020","unstructured":"Jeong, H. et al. B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas. CNS Neurosci. Ther. 26(11), 1147\u201354 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"57253_CR36","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep4.1955","volume":"1948","author":"CA Hudert","year":"2022","unstructured":"Hudert, et al. Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatol. Commun. 1948, 1934\u20131948 (2022).","journal-title":"Hepatol. Commun."},{"key":"57253_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009503","volume":"17","author":"CA Emdin","year":"2021","unstructured":"Emdin, et al. Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease. PLoS Genet. 17, e1009503 (2021).","journal-title":"PLoS Genet."},{"key":"57253_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0959-440X(00)00167-6","volume":"46","author":"JH Laity","year":"2001","unstructured":"Laity, et al. Zinc finger proteins: New insights into structural and functional diversity. Curr. Opin. Struct. Biol. 46, 39\u201346 (2001).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"57253_CR39","first-page":"2065","volume":"19","author":"C Yu","year":"2019","unstructured":"Yu, C. et al. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. Mol. Med. Rep. 19, 2065\u20132076 (2019).","journal-title":"Mol. Med. Rep."},{"key":"57253_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nsmb1038","volume":"167","author":"FC Oberstrass","year":"2006","unstructured":"Oberstrass, et al. Shape-specific recognition in the structure of theVts1p SAM domain with RNA. Nat. Struct. Mol. Biol. 167, 160\u2013167 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"57253_CR41","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1074\/jbc.RA119.011895","volume":"7125","author":"S Ray","year":"2020","unstructured":"Ray, et al. Sterile \u03b1-motif domain requirement for cellular signaling and survival. J. Biol. Chem. 7125, 7113\u20137125 (2020).","journal-title":"J. Biol. Chem."},{"key":"57253_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nsb956","volume":"10","author":"T Aviv","year":"2003","unstructured":"Aviv, T. et al. The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Nat. Struct. Biol. 10, 614\u2013621 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"57253_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/hepr.13984","volume":"54","author":"S Makiuchi","year":"2024","unstructured":"Makiuchi, S. et al. DNA methylation alterations of ADCY5, MICAL2, and PLEKHG2 during the developmental stage of cryptogenichepatocellular carcinoma. Hepatol. Res. 54, 284\u2013299 (2024).","journal-title":"Hepatol. Res."},{"key":"57253_CR44","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMra1402513","volume":"378","author":"AP Feinberg","year":"2018","unstructured":"Feinberg, A. P. et al. The key role of epigenetics in human disease prevention and mitigation. N. Engl. J. Med. 378, 1323\u20131334 (2018).","journal-title":"N. Engl. J. Med."},{"key":"57253_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41574-020-0405-1","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Dietary and metabolic regulation of epigenetic modifications in obesity-related hepatocellular carcinoma. Nat Rev Endocrinol. 16, 683\u2013698 (2020).","journal-title":"Nat Rev Endocrinol."},{"key":"57253_CR46","first-page":"357","volume":"2","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Impact of epigenetic dietary compounds on epigenetic regulation and cancer. Epigenomics 2, 357\u2013377 (2010).","journal-title":"Epigenomics"},{"key":"57253_CR47","doi-asserted-by":"publisher","first-page":"817118","DOI":"10.3389\/fgene.2022.817118","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a diagnostic, prognostic and immunological biomarker in human cancer. Front. Genet. 13, 817118 (2022).","journal-title":"Front. Genet."},{"key":"57253_CR48","first-page":"3599832","volume":"6","author":"P Yang","year":"2022","unstructured":"Yang, P. et al. SHC1 promotes lung cancer metastasis by interacting with EGFR. J. Oncol. 6, 3599832 (2022).","journal-title":"J. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57253-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:21:30Z","timestamp":1788996090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57253-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57253"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57253-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committees of Keio University School of Medicine, the National Cancer Center, the National Center for Global Health and Medicine (currently renamed the Japan Institute for Health Security), Yotsuya Medical Cube, and written informed consent was obtained from all patients. For the US cohort, this study was reviewed and approved by the Institutional Review Board of the University of Utah. As the data analyzed were deidentified and collected in accordance with the institution\u2019s standard of care, the study met criteria for exemption, and informed consent from individual patients was not required.","order":2,"name":"Ethics","label":"Ethical approval and patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28308"}}